(Total Views: 803)
Posted On: 08/14/2020 5:38:52 PM
Post# of 155816
The following has been posted in the NYTimes comment section on the following article by me.
There are only three mentions of Leronlimab in the comment section. Get busy.
"Leronlimab, for all practical purposes, has been shown to be effective as three day turnaround for covid 19. Leronlimab's request for FDA approval is now sitting on the desk of an FDA scientist awaiting review and approval for Emergency Use Authorization (EUA) Keep your fingers crossed the FDA is up to the job on a timely basis. "
https://www.nytimes.com/2020/08/14/health/cov...sContainer
There are only three mentions of Leronlimab in the comment section. Get busy.
"Leronlimab, for all practical purposes, has been shown to be effective as three day turnaround for covid 19. Leronlimab's request for FDA approval is now sitting on the desk of an FDA scientist awaiting review and approval for Emergency Use Authorization (EUA) Keep your fingers crossed the FDA is up to the job on a timely basis. "
https://www.nytimes.com/2020/08/14/health/cov...sContainer
(6)
(0)
